Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Research & Development (2020 - 2025)

Historic Research & Development for IDEAYA Biosciences (IDYA) over the last 6 years, with Q3 2025 value amounting to $83.0 million.

  • IDEAYA Biosciences' Research & Development rose 4521.45% to $83.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $334.9 million, marking a year-over-year increase of 7326.97%. This contributed to the annual value of $294.7 million for FY2024, which is 12753.27% up from last year.
  • As of Q3 2025, IDEAYA Biosciences' Research & Development stood at $83.0 million, which was up 4521.45% from $140.2 million recorded in Q4 2024.
  • IDEAYA Biosciences' 5-year Research & Development high stood at $140.2 million for Q4 2024, and its period low was $11.6 million during Q1 2021.
  • Over the past 5 years, IDEAYA Biosciences' median Research & Development value was $27.9 million (recorded in 2023), while the average stood at $38.5 million.
  • In the last 5 years, IDEAYA Biosciences' Research & Development skyrocketed by 2799.61% in 2023 and then surged by 26157.6% in 2024.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Research & Development stood at $16.1 million in 2021, then surged by 53.4% to $24.7 million in 2022, then skyrocketed by 56.88% to $38.8 million in 2023, then surged by 261.58% to $140.2 million in 2024, then tumbled by 40.8% to $83.0 million in 2025.
  • Its last three reported values are $83.0 million in Q3 2025, $140.2 million for Q4 2024, and $57.2 million during Q3 2024.